1 / 14

Therapy of Type 2 Diabetes Mellitus: UPDATE

Therapy of Type 2 Diabetes Mellitus: UPDATE. Glycemic Goals in the Care of Patients with Type 2 Diabetes- 2013 ADA and AACE Guidelines: Room For Improvement (Be HAPPY/ Avoid Burnout, While Caring for Patients with DM). Stan Schwartz MD, FACP, FACE Affiliate, Main Line Health System

abra-mcpherson
Télécharger la présentation

Therapy of Type 2 Diabetes Mellitus: UPDATE

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Therapy of Type 2 Diabetes Mellitus: UPDATE Glycemic Goals in the Care of Patients with Type 2 Diabetes- 2013 ADA and AACE Guidelines: Room For Improvement (Be HAPPY/ Avoid Burnout, While Caring for Patients with DM) Stan Schwartz MD, FACP, FACE Affiliate, Main Line Health System Clinical Associate Professor of Medicine, Emeritus, U of Pa. stschwar@gmail.com Part 2

  2. Early Treatment Decreases Micro and Macro Vascular RISK

  3. Impact of Intensive Therapy in Type 2 Diabetes Summary of Major Clinical Trials: BUT Subset Evaluations Show Reduced CV Outcomes if shorter duration of DM, without significant pre-existing complications Initial Trial Long Term Follow-up ↑- likely due to hypoglycemia and weight gain

  4. Lancet Meta-analysis 0.9% Dec. HbA1c, 17% Dec. non-fatal MI, 15% Dec. CV events of CAD Probability of events of non-fatal MI with intensive glucose-lowering vs. standard treatment 0.4 0.6 0.8 1.0 1.2 1.4 1.6 1.8 2.0 Intensive treatment better Standard treatment better Probability of events of CAD with intensive glucose-lowering vs. standard treatment 0.4 0.6 0.8 1.0 1.2 1.4 1.6 1.8 2.0 Intensive treatment better Standard treatment better www.thelancet.com. Vol 373 May 23, 2009. *Included on-fatal MI and death from all-cardiac mortality

  5. But Why was there an apparent increase in Mortality in ACCORD, lack of benefit in ADVANCE, VADT • Weight Gain • Hypoglycemia • ACCORD recorded PRIOR history mild severe events- • NO DOCUMENTATION OF GLUCOSE AT TIME OF DEATH

  6. But Why was there an apparent increase in Mortality in ACCORD, lack of benefit in ADVANCE, VADT • Weight Gain • Hypoglycemia • ACCORD recorded PRIOR history mild severe events- • NO DOCUMENTATION OF GLUCOSE AT TIME OF DEATH

  7. Hypoglycemia Outcomes VADT, ACCORD, ADVANCE

  8. Consequences of Hypoglycemia • Prolonged QT- intervals- Diabetologia 52:42,2009 • Can be of pronged duration IJCP Sup 129, 7/02 • Greater with higher catecholamine levels Europace 10,860 • Associated with Angina Diabetes Care 26, 1485, 2003 / Ischemic EKG changes Porcellati, ADA2010 • Associated with Arrhythmias • Associated with Sudden Death Endocrine Practice 16,¾ 2010 • Increased Variabilty- explains highest mortality in intensive group had highest HgA1c in ACCORD ( increases inflammation, ICU mortality Hirsch ADA2010)

  9. VALUE OF CONTROLLING HYPERGLYCEMIA IN HOSPITAL RISK OF TOO TIGHT CONTROL OF HYPERGLYCEMIA IN HOSPITALS

  10. So given epidemiologic data, CV risk/glucose data and now ADVANCE, VADT, ACCORD, implications of weight gain and hypogycemia, what are/ should be goals (SSS) 1. ADA- stayed at <7.0 AACE – stayed at < 6.5 Lowest possible as long as no undue risk of hypoglycemia and visceral weight gain 2. ADA and AACE- • Start early in DM - implications for prevention- lifestyle and drug therapy of metabolic syndrome and IGT b. do not aim for aggressive control in those with significant pre-existing CV disease Disagree- lowest possible without hypoglycemia, weight gain • Modify goals for ‘elderly’ Disagree- lowest possible without hypoglycemia, weight gain

  11. Greater Survival in Elderly (>75yo) with lower HgA1c So… WHY NOT BE AGGRESSIVE IN GLYCEMIC CONTROL IF… NOT USING HYPOGLYCEMIC AGENTS EASD , 9/2010

More Related